Abrdn PLC Immatics N.V. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Immatics N.V. stock. As of the latest transaction made, Abrdn PLC holds 719,586 shares of IMTX stock, worth $7.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
719,586
Previous 719,586
-0.0%
Holding current value
$7.5 Million
Previous $3.25 Million
19.29%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
74Shares Held
93.6MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$191 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$125 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$106 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$97.8 Million2.22% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$72.6 Million0.58% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $794M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...